Nrf2 induces IL-17D to mediate tumor and virus surveillance R Saddawi-Konefka, R Seelige, ETE Gross, E Levy, SC Searles, ... Cell reports 16 (9), 2348-2358, 2016 | 125 | 2016 |
Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity BK Masouleh, GB Ten Dam, MK Wild, R Seelige, J van der Vlag, AL Rops, ... The Journal of Immunology 182 (8), 4985-4993, 2009 | 75 | 2009 |
Immuno-Oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small Molecule Kinase Inhibitor Y Yokoyama, ED Lew, C Walsh, A Diliberto, J Oh, J Lee, E Tindall, ... AACR Tumor Immunology and Immunotherapy Meeting, 2017 | 62 | 2017 |
Endothelial-Specific Gene Ablation of CD99L2 Impairs Leukocyte Extravasation In Vivo R Seelige, C Natsch, S Marz, D Jing, M Frye, S Butz, D Vestweber 15th International Congress of Immunology, 2013 | 37* | 2013 |
Mechanisms regulating immune surveillance of cellular stress in cancer R Seelige, S Searles, JD Bui Cellular and molecular life sciences 75 (2), 225-240, 2018 | 31 | 2018 |
Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection R Seelige, R Saddawi-Konefka, NM Adams, G Picarda, JC Sun, ... Scientific reports 8 (1), 13670, 2018 | 29 | 2018 |
Heparan sulfate expression in the neural crest is essential for mouse cardiogenesis Y Pan, C Carbe, S Kupich, U Pickhinke, S Ohlig, M Frye, R Seelige, ... Matrix Biology 35, 253-265, 2014 | 27 | 2014 |
The ancient cytokine IL-17D is regulated by Nrf2 and mediates tumor and virus surveillance R Seelige, A Washington Jr, JD Bui Cytokine 91, 10-12, 2017 | 26 | 2017 |
Endothelial CD99 supports arrest of mouse neutrophils in venules and binds to neutrophil PILRs D Goswami, S März, YT Li, A Artz, K Schäfer, R Seelige, ... Blood, The Journal of the American Society of Hematology 129 (13), 1811-1822, 2017 | 24 | 2017 |
CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation M Samus, R Seelige, K Schäfer, L Sorokin, D Vestweber Journal of leukocyte biology 104 (4), 787-797, 2018 | 19 | 2018 |
Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief Report A Meier, E Gross, Emilie T., M Schilling, Jan, R Seelige, Y Jung, ... Anesthesia and Analgesia, 2018 | 16 | 2018 |
Innate sensing of cancer's non-immunologic hallmarks R Seelige, S Searles, JD Bui Current opinion in immunology 50, 1-8, 2018 | 12 | 2018 |
Immuno-Oncological Efficacy of RXDX-106, a Novel Small Molecule Inhibitor of the TAM (TYRO3, AXL, MER) Family of Kinases Y Yokoyama, ED Lew, R Seelige, EA Tindall, C Walsh, PC Fagan, JY Lee, ... Cancer Res 79 (8), 1996-2008, 2019 | 8 | 2019 |
Immuno-oncological efficacy of RXDX-106, a novel, selective and potent small molecule TAM (TYRO3, AXL, MER) inhibitor Y Yokoyama, ED Lew, R Seelige, C Walsh, M Barrera, E Tindall, J Oh, ... Cancer Research 77 (13_Supplement), 4698-4698, 2017 | 2 | 2017 |
The Nrf2/ Interleukin-17D axis as a novel target for cancer immune therapy R Seelige, R Saddawi-Konefka, ETE Gross, E Levy, SC Searles, ... AAI Immunology 2017, 2017 | 1 | 2017 |
1367 A highly-selective HPK1 inhibitor enhances T cell receptor signaling and T cell activation potential, increasing antigen recognition and efficacy of PD-1 therapy A Nager, D Schaer, R Gallego, E Hendrickson, S Timofeevski, M Li, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
Strategies for improving the analysis of the tumor microenvironment 2nd Annual Advances in Immuno-Oncology, 2019 | | 2019 |
Cell death-inducing reagents activate cancer immune surveillance via inducing Interleukin-17D in macrophages R Seelige, JD Bui AAI Immunology 2018, 2018 | | 2018 |
Immuno-oncological efficacy of RXDX-106, a novel TAM (TYRO3, AXL, MER) family small molecule kinase inhibitor E Lew, Y Yokoyama, C Walsh, J Lee, J Oh, E Tindall, R Nevarez, ... SITC Meeting 2017, 2017 | | 2017 |
Cancer-intrinsic activation of the oxidative stress sensor Nrf2 induces the cytokine Interleukin-17D to mediate tumor surveillance R Seelige, R Saddawi-Konefka, ETE Gross, E Levy, SC Searles, ... La Jolla Immunology Conference, 2017 | | 2017 |